News
News

The latest updates from AFAR.

Grantee in the News: David Walker Identifies Gene That May Slow Aging Process

Sep 4
2014

Grantee in the News: David Walker Identifies Gene That May Slow Aging Process

On September 4, 2014, Cell Reports released research authored by 2009 AFAR Award recipient, David Walker, Ph.D., showing that activation of the gene AMPK in fruit flies increased average lifespan by 30%, from roughly 6 to 8 weeks. AMPK, a gene that also exists in humans, is a key energy sensor in cells and is activated only when cellular energy is low.  Once activated, AMPK helps to cleanse the cell of old and damaged cellular components.  Dr. Walker’s team found that activating the gene in one organ, such as the easier to access intestines, also initiated AMPK in harder…


View MoreREAD MORE


Grantee in the News: Ozioma Okonkwo honored at Alzheimer’s International Conference

Aug 19
2014

Grantee in the News: Ozioma Okonkwo honored at Alzheimer’s International Conference

2013 Beeson Scholar Ozioma Okonkwo, Ph.D. was recently recognized by the Alzheimer’s Association for his contributions at the Alzheimer’s Association International Conference 2014 (AAIC), held July 12-17, in Copenhagen, Denmark. Ozioma Okonkwo, PhD, an investigator and co-leader of the center’s neuropsychology service, received the Alzheimer’s Imaging Consortium 2014 Best Oral Presentation Award for his oral presentation Physical activity modifies Alzheimer’s biomarkers in preclinical Alzheimer’s disease: Evidence from the Wisconsin Registry for Alzheimer’s Prevention. At the conference, Dr. Okonkwo presented research stating that participating in game play and…


View MoreREAD MORE


Grantee in the News: Dr. David Holtzman Weighs in on New Alzheimer’s Finding in the NY Times

Aug 14
2014

Grantee in the News: Dr. David Holtzman Weighs in on New Alzheimer’s Finding in the NY Times

In an August 11, 2014 article, the New York Times reported on a promising new finding in the fight to Alzheimer’s disease, siting the comments and research of 1995 Beeson Scholar, AFAR Grant Application Reviewer, 2012 Chair of the MetLife Awards Committee (administered by AFAR), David Holtzman, M.D. The article shared research stating that APOE, a gene which makes a protein related to cholesterol transportation that has been linked to build-up of the plaques associated with increased risk of developing Alzheimer’s disease, may not be critical for normal brain development and function. Dr. Holtzman, who’s earlier research…


View MoreREAD MORE


AFAR in the News: AFAR Pilot Study Funding Opens the Door to Major NIH Grant for Frailty Study

Aug 14
2014

AFAR in the News: AFAR Pilot Study Funding Opens the Door to Major NIH Grant for Frailty Study

On August 8, 2014, Albert Einstein College of Medicine reported on a 5-year $3.3 million grant received from the National Institutes of Health (NIH) for a study entitled, "Role of exceptional longevity genotypes in protection against frailty in aging."  Nir Barzilai, M.D., a three-time grantee and AFAR’s Deputy Scientific Director and 2004 Beeson Scholar Joe Verghese, M.D., will serve as the principal investigators.  This study, which will expand efforts to identify gene variants that keep frailty at bay, explore biological pathways that lead to frailty, and develop drugs that mimic the effects of frailty-preventing genes, is…


View MoreREAD MORE


Grantee in the News: Anna Goldenheim Releases Study on the Rehospitalization of Patients Discharged to Hospice Care

Aug 6
2014

Grantee in the News: Anna Goldenheim Releases Study on the Rehospitalization of Patients Discharged to Hospice Care

The July 17, 2014 issue of the Journal of Palliative Medicine featured research by 2011 Medical Student Training in Aging Research (MSTAR) Program Scholar, Anna Goldenheim.  The article, co-authored by Goldenheim, focuses on the 30-day readmission of patients discharged to home hospice care. Hospice care is an option for patients at the end of life who choose to forego curative treatment. It offers symptom management, as well as emotional and spiritual support for patients and families. Little is known about the characteristics of hospice patients who are readmitted to hospitals within 30 days of discharge with home hospice care. The study…


View MoreREAD MORE




BACK TO TOPBACK TO TOP